J. Mrochem-Kwarciak

发表

1H NMR based metabolomic approach to monitoring of the head and neck cancer treatment toxicity

Ł. Boguszewicz, A. Hajduk, J. Mrochem-Kwarciak, 2016, Metabolomics.

NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients

A. Wygoda, Ł. Boguszewicz, J. Mrochem-Kwarciak, 2019, Metabolomics.

[Usefulness of osteopontin (OPN) determinations in ovarian cancer patients who underwent first-line chemotherapy].

J. Mrochem-Kwarciak, A. Chmura, R. Deja, 2011, Ginekologia polska.

Analysis of Selected Nutritional Parameters in Patients with HPV-Related and Non-HPV-Related Oropharyngeal Cancer before and after Radiotherapy Alone or Combined with Chemotherapy

T. Rutkowski, J. Mrochem-Kwarciak, K. Składowski, 2022, Cancers.

Comparison of Selected Immune and Hematological Parameters and Their Impact on Survival in Patients with HPV-Related and HPV-Unrelated Oropharyngeal Cancer

T. Rutkowski, J. Mrochem-Kwarciak, K. Składowski, 2021, Cancers.

Overall survival analysis of > 65-year-old patients with breast cancer based on their molecular, clinicopathological and laboratory factors

E. Grzybowska, J. Mrochem-Kwarciak, Z. Kołosza, 2022, Archives of medical science : AMS.

Early diagnosis of radiotherapy failure for patients with head and neck cancer: the role of biochemical markers

T. Rutkowski, A. Wygoda, A. Hajduk, 2018, Tumori.

CYFRA 21-1 as a Prognostic Marker of Tumor Response to Radiation Alone or Combined With Chemotherapy in Patients With Carcinoma of Larynx or Hypopharynx

P. Widłak, T. Rutkowski, A. Wygoda, 2015 .

NMR-Based Metabolomics in Investigation of the Radiation Induced Changes in Blood Serum of Head and Neck Cancer Patients and Its Correlation with the Tissue Volumes Exposed to the Particulate Doses

J. Wendykier, Ł. Boguszewicz, J. Mrochem-Kwarciak, 2021, International journal of molecular sciences.

Systemic Effects of Radiotherapy and Concurrent Chemo-Radiotherapy in Head and Neck Cancer Patients—Comparison of Serum Metabolome Profiles

J. Polańska, P. Widłak, T. Rutkowski, 2020, Metabolites.

Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer

D. Butkiewicz, J. Mrochem-Kwarciak, R. Suwiński, 2019, BMC Cancer.

Escalating a Biological Dose of Radiation in the Target Volume Applying Stereotactic Radiosurgery in Patients with Head and Neck Region Tumours

A. Grządziel, P. Polanowski, J. Mrochem-Kwarciak, 2022, Biomedicines.

The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma

T. Rutkowski, J. Mrochem-Kwarciak, K. Składowski, 2019, Oncology.

Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients

J. Mrochem-Kwarciak, Z. Kołosza, J. Huszno, 2020, Oncology.

1H NMR based metabolomic approach to monitoring of the head and neck cancer treatment toxicity

Ł. Boguszewicz, A. Hajduk, J. Mrochem-Kwarciak, 2016, Metabolomics.

Role of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio and platelets in prognosis of patients with prostate cancer.

J. Mrochem-Kwarciak, L. Miszczyk, B. Jochymek, 2022, Oncology letters.

A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy

B. Buszewski, P. Pomastowski, J. Mrochem-Kwarciak, 2022, Biomedicines.

Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer

D. Butkiewicz, J. Mrochem-Kwarciak, R. Suwiński, 2019, BMC cancer.

1H NMR based metabolomic approach to monitoring of the head and neck cancer treatment toxicity

Ł. Boguszewicz, A. Hajduk, J. Mrochem-Kwarciak, 2016, Metabolomics.

C-Reactive Protein as a Biomarker of Radiation Therapy and Chemotherapy Toxicity Monitoring in Patients With Head and Neck Cancer

P. Polanowski, T. Rutkowski, A. Wygoda, 2016 .

Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis

E. Chmielik, A. Hebda, T. Rutkowski, 2023, Scientific Reports.

Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Ł. Boguszewicz, J. Mrochem-Kwarciak, A. Skorupa, 2023, International journal of molecular sciences.

Urine microbiome changes during and after radiotherapy for prostate cancer

P. Pomastowski, M. Pietrowska, J. Mrochem-Kwarciak, 2024, bioRxiv.

Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study

Ł. Boguszewicz, J. Mrochem-Kwarciak, A. Skorupa, 2024, Metabolites.